Blog

4 Reasons to meet Huma at OCT Europe '23 | 3-4 May, Barcelona

April 24, 2023
Blog

4 Reasons to meet Huma at OCT Europe '23 | 3-4 May, Barcelona

April 24, 2023

This is some text inside of a div block.
mins read
Speaker shot.

Speaker shot.

Speaker shot.

Digital Trials are about to drive a huge leap forward and Huma is on a mission to help you make it happen. Meet us as we tour Europe this year to uncover what is next in the digital-first research space.

This year, Huma is proud to sponsor three Outsourcing in Clinical Trials conferences across Europe, with our first instalment of the series taking place at the Hyatt Regency Barcelona Tower (Barcelona, Spain) on the 3rd and 4th of May.  Now in its 13th year, this event gathers the greatest minds in Clinical Operations, Project and Data Management across Pharmaceutical, Biotech, and more. Together, this community will discuss the latest trends, challenges and opportunities facing the industry with a particular focus on Technology, Innovation, Strategy and Planning. 

If you’re headed to the conference, make sure to keep some time in your diary to meet with Huma’s Digital Clinical Trials (DCT) team. Here are four reasons why you should connect with us:

1. Digital Clinical Trials are taking centre stage

This year, no less than seven sessions, including a closing keynote, will be discussing Digital Clinical Trials, not to mention other pressing challenges including - but not limited to:

  • Digitising research projects at scale
  • Managing regulatory expectations from software compliance to electronic consent 
  • Deriving meaningful insights from wearables and IoMT devices 
  • Engaging participants beyond recruitment stages
  • And more…

With lessons learned, best practices and future outlook, experts are set to share insights and ideas that will undoubtedly shape the next phase of digital-first clinical research. 

Could this knowledge-sharing appetite be an early indicator of where clinical research operations, data collection and the participant experience are headed? We, at Huma, truly believe that our digital platform is a game changer and we would love to show you how we can help you drive towards your research priorities.

2. Meet a team of experts

With an award-winning platform and years of expertise in digital-first care and research, Huma is proud to be part of this ecosystem and to help people live longer, fuller lives. Behind our purpose are incredible individuals transforming healthcare and research. Three of them will be at conference to meet you:

  • Clare Burn - Business Development Director, Digital Clinical Trials
  • Marta Chodorek - Business Development Director, Digital Clinical Trials

Dennis, Clare and Marta spend their day-to-day speaking with Pharmaceutical and BioTech companies, Academics and CROs to understand the pain points faced by the industry when implementing complex protocols across a variety of therapeutic areas. Oftentimes, deploying technological resources can solve multiple business challenges, but it is always better leveraged when combined with human expertise. Our team is here to ensure that the solutions you will adopt are not only compliant and secure, but also adaptable and easy to implement at speed and scale. Ultimately, ensuring that your technology investment drives sustainable outcomes for you and your participants alike is paramount.

3. Delivering value across the entire clinical trial lifecycle

In January 2023, to advance our expertise and operational know-how even further, Huma acquired Alcedis, a market-leader for data-driven clinical research and technology. Through the acquisition, Huma is forming an advanced clinical trials division offering digital solutions across the trial development pipeline, combining award-winning technology with scientific expertise acquired over 25 years. 

By joining forces we are able to examine, advise, plan and fully deliver trials on a global scale and supported by best-in-class modular technology. This makes it easier for you to deliver a study for your specific therapeutic area quickly and efficiently, utilising our expertise in conjunction with agile technology and collecting high-quality data specific to your therapeutic protocol. Whether your project requires integration with a client’s EDC, protocol changes or trial variations, our highly flexible platform can support you throughout your journey and without having to go back to the drawing board.

4. Win a pair of Apple Airpods - courtesy of Huma!

Last but not least, we will be giving away a pair of Apple Airpods to one of our lucky visitors. Simply find us at the conference throughout the two days and sign up for our prize draw to be in for a chance to win*. Even better, you could also block some time with us by scheduling a meeting below. 

There are many more reasons to connect with the Huma team at Outsourcing in Clinical Trials Europe but we think that this early preview is a good starting point. We are looking forward to meeting you at the conference! 

*Terms and Conditions apply.

This field is required
Email must be formatted correctly
This field is required
This field is required
This field is required

Huma is committed to respecting your privacy, we’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes. You can unsubscribe at any time. Review our Privacy Policy for further information.

Keep up to date on our current work and research with the latest marketing updates from Huma, including monthly news, events and communications on products and services.

By clicking submit below, you consent to allow Huma to store and process the personal information submitted above to provide you the content requested.

One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.

This field is required
This field is required
This field is required
This field is required
Thank you for your request.
You will receive an email from us shortly containing the file. Please check your inbox (and promotions tab or spam folder, if necessary) for the email.
Oops! Something went wrong while submitting the form

Book a meeting

Email must be formatted correctly
This field is required
This field is required
This field is required
This field is required
This field is required
Country/Region*
This field is required
I'm interested in

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

You’re in control. You can, of course, withdraw your consent at any time. Review our Privacy Policy for further information.

One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.

Making an impact

3000+

3000+ hospitals and clinics supported across Huma platforms to secure the most sustainable impact for patients1

×2

Our platform can almost double clinical capacity and reduce readmission rates by >30%3

27m+

Huma's digital-first health platforms support a network of 27m patients1

1m+

Over 1 million devices have been shipped in support of our projects and we know what it takes to deploy at scale1

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Selected as one of 'The Most Important Healthcare Design of 2021' by Fast Company5

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Sources:

Blog

4 Reasons to meet Huma at OCT Europe '23 | 3-4 May, Barcelona

April 24, 2023
Blog

4 Reasons to meet Huma at OCT Europe '23 | 3-4 May, Barcelona

April 24, 2023

Huma joins digital pioneers to advance health equity in care and research

Chief Executive Officer and Founder, Dan Vahdat, is returning to the annual World Economic Forum’s main conference where he will join a panel discussion devoted to improving care for non-communicable disease and tackling health equity. Accompanied by Chief Financial and Strategy Officer, Ingeborg Oie, Dan is looking forward to connecting with other attendees to explore how Huma’s digital health platform can make healthcare more equitable, and advances proactive, predictive care.

Huma joins digital pioneers to advance health equity in care and research

Date:Wednesday, January 18, 2023
Time:4:15 - 5:15 p.m. CET
Location:Ice Village, Eisbahnstrasse 5, Davos, Switzerland
Dan will join the Digital Health Action Alliance panel at Davos to discuss Turning the Tide in Non-Communicable Disease Care Through Digital Health and Community Connection. Huma has a long history of advancing the care of non-communicable diseases (NCDs) such as heart disease, cancer, diabetes and lung conditions. Huma’s innovative remote patient monitoring platform enables broad patient recruitment, reduces reliance on in-person clinic visits and increases health system efficiency.
*This session is open to registered Annual Meeting 2023 participants and Affiliate badge holders.

Huma is one of the first to sign the Zero Health Gaps Pledge

Huma is one of the first signatories to the Zero Health Gaps Pledge, the World Economic Forum’s Global Health Equity Network’s (GHEN) initiative. Huma supports GHEN’s ambition to build a future without disparities in health or wellbeing outcomes. Huma’s digital platform has been built on a deep clinical knowledge of complex patient needs and how people engage with technology and we are committed to ensuring our technology promotes health equity. We are proud to work with governments, hospital groups, universities, life science and technology companies to bring greater scale and impact and help all people live longer, fuller lives.

Huma at World Economic Forum

Global Innovators and Tech Pioneers
Dec 2022: Huma selected to join 100 innovative companies on a two-year journey as part of the World Economic Forum’s initiatives, activities and events, bringing their cutting-edge insight and fresh thinking to critical global discussions.
Learn more
Working Together, Restoring Trust
May 2022: With the aim to address economic, environmental, political, and social fault-lines exacerbated by the COVID-19 pandemic, Dan Vahdat speaks at WEF annual meeting about the importance of scientific collaboration.
Learn more
Accelerating innovation and breaking new ground
October 2022: Dan joined the WEF Biotech Future Forum 2022 to discuss how start-ups are breaking new ground in biotech and changing the way we interact with the world, but also how the sector can earn trust, scale successfully and spot the brightest innovations.
Learn more
Making connections at Davos
Jan 2019: Dan attended WEF as an unofficial attendee and spoke to CNBC about the importance of meeting in-person to make connections.
Learn more

Related Articles

See more
Article
AI is in our DNA
Explore how Huma has been developing AI to revolutionise healthcare, and request a meeting with us to find out more.
Learn more
Article
“It’s really gold dust” Why Huma is a big step forward for knee surgery
Discover how Huma is providing Smith+Nephew with real world evidence for robotic knee replacement surgery.
Learn more

Related Blogs

See more
Blog
Feeling depressed linked to short-term increase in bodyweight, study finds
Learn more
Blog
How Huma is transforming Health
Tim Broke-Smith, Huma's Vice President, Global Pharma Partnerships, considers how cutting edge technology can transform healthcare.
Learn more

Related Ebooks

See more
Ebook
Welcome to next-generation digital-first care and research
Deliver more personalised digital-first care and research with the first disease agnostic enterprise platform to achieve EU MDR Class IIb certification1.
Learn more
Ebook
What does FDA 510(k) Class II mean for Huma and our partners
Deliver more personalised digital-first care and research with our enterprise platform which now has FDA 510 (K) Class II clearance for any physician-specified condition.
Learn more

Related White Papers

See more
White Paper
Navigating the DCT transition
Learn how remote trial technology is changing the clinical trial landscape and key considerations when including DCT components in your study protocols.
Learn more
Blog

4 Reasons to meet Huma at OCT Europe '23 | 3-4 May, Barcelona

April 24, 2023
Media contact
A headshot of Karen Birmingham PhD
Karen Birmingham PhD
Head of PR & Communications
karen.birmingham@huma.com
Blog

4 Reasons to meet Huma at OCT Europe '23 | 3-4 May, Barcelona

April 24, 2023
Media contact
A headshot of Karen Birmingham PhD
Karen Birmingham PhD
Head of PR & Communications
karen.birmingham@huma.com

Digital Trials are about to drive a huge leap forward and Huma is on a mission to help you make it happen. Meet us as we tour Europe this year to uncover what is next in the digital-first research space.

This year, Huma is proud to sponsor three Outsourcing in Clinical Trials conferences across Europe, with our first instalment of the series taking place at the Hyatt Regency Barcelona Tower (Barcelona, Spain) on the 3rd and 4th of May.  Now in its 13th year, this event gathers the greatest minds in Clinical Operations, Project and Data Management across Pharmaceutical, Biotech, and more. Together, this community will discuss the latest trends, challenges and opportunities facing the industry with a particular focus on Technology, Innovation, Strategy and Planning. 

If you’re headed to the conference, make sure to keep some time in your diary to meet with Huma’s Digital Clinical Trials (DCT) team. Here are four reasons why you should connect with us:

1. Digital Clinical Trials are taking centre stage

This year, no less than seven sessions, including a closing keynote, will be discussing Digital Clinical Trials, not to mention other pressing challenges including - but not limited to:

  • Digitising research projects at scale
  • Managing regulatory expectations from software compliance to electronic consent 
  • Deriving meaningful insights from wearables and IoMT devices 
  • Engaging participants beyond recruitment stages
  • And more…

With lessons learned, best practices and future outlook, experts are set to share insights and ideas that will undoubtedly shape the next phase of digital-first clinical research. 

Could this knowledge-sharing appetite be an early indicator of where clinical research operations, data collection and the participant experience are headed? We, at Huma, truly believe that our digital platform is a game changer and we would love to show you how we can help you drive towards your research priorities.

2. Meet a team of experts

With an award-winning platform and years of expertise in digital-first care and research, Huma is proud to be part of this ecosystem and to help people live longer, fuller lives. Behind our purpose are incredible individuals transforming healthcare and research. Three of them will be at conference to meet you:

  • Clare Burn - Business Development Director, Digital Clinical Trials
  • Marta Chodorek - Business Development Director, Digital Clinical Trials

Dennis, Clare and Marta spend their day-to-day speaking with Pharmaceutical and BioTech companies, Academics and CROs to understand the pain points faced by the industry when implementing complex protocols across a variety of therapeutic areas. Oftentimes, deploying technological resources can solve multiple business challenges, but it is always better leveraged when combined with human expertise. Our team is here to ensure that the solutions you will adopt are not only compliant and secure, but also adaptable and easy to implement at speed and scale. Ultimately, ensuring that your technology investment drives sustainable outcomes for you and your participants alike is paramount.

3. Delivering value across the entire clinical trial lifecycle

In January 2023, to advance our expertise and operational know-how even further, Huma acquired Alcedis, a market-leader for data-driven clinical research and technology. Through the acquisition, Huma is forming an advanced clinical trials division offering digital solutions across the trial development pipeline, combining award-winning technology with scientific expertise acquired over 25 years. 

By joining forces we are able to examine, advise, plan and fully deliver trials on a global scale and supported by best-in-class modular technology. This makes it easier for you to deliver a study for your specific therapeutic area quickly and efficiently, utilising our expertise in conjunction with agile technology and collecting high-quality data specific to your therapeutic protocol. Whether your project requires integration with a client’s EDC, protocol changes or trial variations, our highly flexible platform can support you throughout your journey and without having to go back to the drawing board.

4. Win a pair of Apple Airpods - courtesy of Huma!

Last but not least, we will be giving away a pair of Apple Airpods to one of our lucky visitors. Simply find us at the conference throughout the two days and sign up for our prize draw to be in for a chance to win*. Even better, you could also block some time with us by scheduling a meeting below. 

There are many more reasons to connect with the Huma team at Outsourcing in Clinical Trials Europe but we think that this early preview is a good starting point. We are looking forward to meeting you at the conference! 

*Terms and Conditions apply.

asdasd

asda

asdsads

asda

asdsad

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Download
Share this
COMPANY

About Huma

Huma began its journey in 2011, when the company was founded in London. Since then, Huma has grown to become a global healthcare company, spanning across multiple geographies and operating across four continents.

Learn more